Inflarx Gmbh

This study tested a drug called vilobelimab for people with a rare, painful skin condition that causes deep ulcers. The goal was to see if the drug could help close these wounds better than a placebo. The trial was stopped early, and results are not yet available.

This study tested an oral medication called INF904 in adults with moderate to severe chronic hives or hidradenitis suppurativa (a painful skin condition). The main goal was to check the drug's safety and how it moves through the body over a 28-day treatment period. The trial was …